Wells Fargo Maintains Overweight on MyoKardia, Raises Price Target to $96

Wells Fargo maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $82 to $96.

Benzinga · 01/17/2020 14:59

Wells Fargo maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $82 to $96.